Published in Int J Cancer on September 15, 1980
Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa. Nat Rev Clin Oncol (2013) 1.44
Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Br J Haematol (2011) 1.39
Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer (1982) 1.01
Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis. Adv Hematol (2012) 0.87
Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol (2016) 0.85
Abdominal Burkitt-type lymphomas in Algeria. Br J Cancer (1984) 0.82
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease. Br J Haematol (2012) 0.81
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. BMC Clin Pathol (2009) 0.80
T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: hypothesis. Infect Agent Cancer (2007) 0.75
Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. Adv Hematol (2012) 0.75
Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi. Glob Pediatr Health (2017) 0.75
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1991) 3.69
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.93
Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet (1982) 2.58
Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44
Clinical trial of malaria prophylaxis in tropical splenomegaly syndrome. Br Med J (1971) 2.44
Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer (1971) 2.06
Binding and suppression of the Myc transcriptional activation domain by p107. Science (1994) 1.84
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood (1994) 1.79
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73
Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood (1991) 1.73
A computer simulation of the EPI survey strategy. Int J Epidemiol (1985) 1.73
Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clin Immunol Immunopathol (1986) 1.68
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med (1979) 1.61
Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59
Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement. Mol Cell Biol (1985) 1.56
A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells. Anal Biochem (1991) 1.55
Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. J Immunol (1982) 1.55
Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis (1996) 1.53
A stress discussion group for medical interns. J Med Educ (1984) 1.52
Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. AIDS Res Hum Retroviruses (2008) 1.51
B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. J Clin Invest (1980) 1.51
Immunological studies in Kaposi's sarcoma in Uganda. Br Med J (1970) 1.47
Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol (1979) 1.46
Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA. Proc Natl Acad Sci U S A (1973) 1.44
Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A (1988) 1.43
Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst (1971) 1.43
Immunological effects of BCG in malignant melanoma: two modes of administration compared. Ann Intern Med (1972) 1.43
Cryoglobulinaemia in tropical splenomegaly syndrome. Clin Exp Immunol (1973) 1.42
Regression of Burkitt's lymphoma in association with measles infection. Lancet (1971) 1.41
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol (1983) 1.37
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med (1980) 1.36
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med (1978) 1.35
Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health (1999) 1.34
Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer (1989) 1.34
Burkitt's lymphoma: a time-space cluster of cases in Bwamba County of Uganda. Br Med J (1971) 1.34
Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet (1983) 1.34
Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer (1996) 1.34
Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene (1996) 1.32
Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol (1986) 1.31
Pregnancy outcome following cancer chemotherapy. Am J Med (1980) 1.30
Anaemia in African trypanosomiasis and 'big spleen disease' in Uganda. Trans R Soc Trop Med Hyg (1973) 1.30
Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer (1975) 1.29
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
Burkitt's lymphoma. N Engl J Med (1981) 1.29
Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet (1990) 1.28
Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet (1970) 1.27
Estimation and projection of adult AIDS cases: a simple epidemiological model. Bull World Health Organ (1991) 1.25
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21
Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med (1976) 1.21
Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA (1994) 1.19
Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol (1987) 1.19
Medical presentations of choriocarcinoma. Br Med J (1971) 1.17
Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res (1980) 1.17
Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16
Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Semin Oncol (1984) 1.16
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. J Natl Cancer Inst (1980) 1.15
The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res (1992) 1.14
Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer (2004) 1.14
Surgical reduction of tumour bulk in management of abdominal Burkitt's lymphoma. Br Med J (1974) 1.13
An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood (1984) 1.12
Immunological studies in tropical splenomegaly syndrome in Uganda. Br Med J (1969) 1.11
Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol (1997) 1.11
p53 expression in Langerhans cell histiocytosis. J Pediatr Hematol Oncol (1998) 1.10
Absence of sickle trait in patients with tropical splenomegaly syndrome. Lancet (1969) 1.10
T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol (1982) 1.08
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer (1977) 1.08
Cure of Burkitt's lymphoma. Ten-year follow-up of 157 Ugandan patients. Lancet (1979) 1.07
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood (1978) 1.07
Complement receptor expression by neoplastic and normal human cells. J Immunol (1983) 1.07
Causes of death in patients with burkitt's lymphoma--the role of supportive care in overall management. East Afr Med J (1974) 1.07
Relapse patterns in Burkitt's lymphoma. Cancer Res (1972) 1.05
Chemotherapy of Burkitt's lymphoma. Cancer (1972) 1.02
Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Baltimore) (1981) 1.02
Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. Blood (1994) 1.02
Familial cases of endomyocardial fibrosis in Uganda. Br Med J (1971) 1.01
Cytogenetic studies in non-African Burkitt lymphoma. Blood (1980) 1.01
Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene. J Gen Virol (2001) 1.01
HIV and design of intervention studies for control of sexually transmitted diseases. AIDS (1990) 1.01
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer (1974) 1.01
Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol (1999) 1.00
Echocardiographic diagnosis of heart disease in Uganda. Trop Doct (1996) 1.00
Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med (1977) 0.99
NIH clinical staff conference. Burkitt's tumor. Ann Intern Med (1969) 0.98
Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia. Cancer Res (1996) 0.98
Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease. J Clin Oncol (1990) 0.97
A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer (1975) 0.96